Related Experiment Videos
Can exogenous stem cells be used in transplantation?
1National Institute on Aging, Intramural Research Program, Gerontology Research Center, Laboratory of Cardiovascular Science, Baltimore, MD, USA.
Cells, Tissues, Organs
|December 11, 1999
Summary
Embryonic stem cells offer a renewable source for cell therapy, potentially addressing organ shortages. Research reviews advances in murine and human stem cells for transplantation, highlighting potential and challenges.
Area of Science:
- Regenerative Medicine
- Stem Cell Biology
- Transplantation Science
Background:
- Organ and tissue shortages are critical challenges in transplantation, exacerbated by aging populations.
- Cell therapy aims to replace or repair damaged tissues, requiring a renewable cell source.
- Embryonic stem (ES) cells possess self-renewal and pluripotency, differentiating into all three germ layers.
Purpose of the Study:
- To review advances in murine embryonic stem cell research.
- To explore the potential and challenges of using human embryonic stem cells for transplantation.
- To assess ES cells as an alternative to organ transplantation.
Main Methods:
- Review of existing literature on murine and human embryonic stem cell research.
- Analysis of ES cell proliferation, differentiation, and genetic modification capabilities.
- Evaluation of therapeutic potential and obstacles for clinical application.
Main Results:
- Murine ES cells demonstrate potential for in vitro proliferation and differentiation.
- Human ES cells have been isolated and maintained in culture, showing therapeutic promise.
- Significant obstacles remain for the clinical use of human ES cells in transplantation.
Conclusions:
- Embryonic stem cells represent a promising renewable source for cell-based therapies.
- Further research is needed to overcome challenges in utilizing human ES cells for transplantation.
- Cellular transplantation using ES cells could potentially alleviate organ donor scarcity.